MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis

Barcellos-Hoff, 2013, The evolution of the cancer niche during multistage carcinogenesis, Nat. Rev. Cancer, 13, 511, 10.1038/nrc3536 Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 Battula, 2012, Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis, J. Clin. Invest., 122, 2066, 10.1172/JCI59735 Bockmeyer, 2011, MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes, Breast Cancer Res. Treat., 130, 735, 10.1007/s10549-010-1303-3 Brenner, 2011, MicroRNAs as a potential prognostic factor in gastric cancer, World J. Gastroenterol., 17, 3976, 10.3748/wjg.v17.i35.3976 2012, Comprehensive molecular portraits of human breast tumours, Nature, 490, 61, 10.1038/nature11412 Chaturvedi, 2013, Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis, J. Clin. Invest., 123, 189, 10.1172/JCI69244 Chen, 2010, Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue, Breast Cancer Res. Treat., 119, 335, 10.1007/s10549-009-0344-y Cimino, 2013, miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1, FASEB J, 27, 1223, 10.1096/fj.12-214692 Cuiffo, 2012, Mesenchymal stem cells in tumor development: emerging roles and concepts, Cell Adhes. Migr., 6, 220, 10.4161/cam.20875 Dedeurwaerder, 2011, DNA methylation profiling reveals a predominant immune component in breast cancers, EMBO Mol Med, 3, 726, 10.1002/emmm.201100801 Dorado, 2011, Pancreatic cancer stem cells: new insights and perspectives, J. Gastroenterol., 46, 966, 10.1007/s00535-011-0422-x Drews-Elger, 2014, Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures, Breast Cancer Res. Treat., 144, 503, 10.1007/s10549-014-2887-9 El-Haibi, 2012, Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy, Proc. Natl. Acad. Sci. USA, 109, 17460, 10.1073/pnas.1206653109 Farazi, 2011, MicroRNA sequence and expression analysis in breast tumors by deep sequencing, Cancer Res., 71, 4443, 10.1158/0008-5472.CAN-11-0608 Feber, 2011, MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma, Ann. Thorac. Surg., 91, 1523, 10.1016/j.athoracsur.2011.01.056 Fisher, 2009, FOXP2 as a molecular window into speech and language, Trends Genet., 25, 166, 10.1016/j.tig.2009.03.002 Ginestier, 2007, ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome, Cell Stem Cell, 1, 555, 10.1016/j.stem.2007.08.014 Goldstein, 2010, Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis, Cancer Res., 70, 10044, 10.1158/0008-5472.CAN-10-1254 Hanson, 2013, Comparative analysis of adipose-derived mesenchymal stem cells isolated from abdominal and breast tissue, Aesthet. Surg. J., 33, 888, 10.1177/1090820X13496115 Hu, 2009, ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, J. Immunol. Methods, 347, 70, 10.1016/j.jim.2009.06.008 Hu, 2008, Regulation of in situ to invasive breast carcinoma transition, Cancer Cell, 13, 394, 10.1016/j.ccr.2008.03.007 Iorio, 2007, MicroRNA signatures in human ovarian cancer, Cancer Res., 67, 8699, 10.1158/0008-5472.CAN-07-1936 Jung, 2013, Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis, Nat Commun, 4, 1795, 10.1038/ncomms2766 Karnoub, 2007, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, 449, 557, 10.1038/nature06188 Konopka, 2009, Human-specific transcriptional regulation of CNS development genes by FOXP2, Nature, 462, 213, 10.1038/nature08549 Li, 2004, Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions, Mol. Cell. Biol., 24, 809, 10.1128/MCB.24.2.809-822.2004 Liu, 2009, p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo, Proc. Natl. Acad. Sci. USA, 106, 19035, 10.1073/pnas.0910009106 Liu, 2011, Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks, Cancer Res., 71, 614, 10.1158/0008-5472.CAN-10-0538 Ma, 2007, Tumour invasion and metastasis initiated by microRNA-10b in breast cancer, Nature, 449, 682, 10.1038/nature06174 Malanchi, 2012, Interactions between cancer stem cells and their niche govern metastatic colonization, Nature, 481, 85, 10.1038/nature10694 Mascaux, 2009, Evolution of microRNA expression during human bronchial squamous carcinogenesis, Eur. Respir. J., 33, 352, 10.1183/09031936.00084108 McLean, 2011, Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production, J. Clin. Invest., 121, 3206, 10.1172/JCI45273 Miller, 2005, An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival, Proc. Natl. Acad. Sci. USA, 102, 13550, 10.1073/pnas.0506230102 Miyoshi, 2011, Reprogramming of mouse and human cells to pluripotency using mature microRNAs, Cell Stem Cell, 8, 633, 10.1016/j.stem.2011.05.001 Myatt, 2007, The emerging roles of forkhead box (Fox) proteins in cancer, Nat. Rev. Cancer, 7, 847, 10.1038/nrc2223 Nair, 2014, c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer, Oncogene, 33, 3992, 10.1038/onc.2013.368 Okamoto, 2007, Expression of HOXC9 and E2F2 are up-regulated in CD133(+) cells isolated from human astrocytomas and associate with transformation of human astrocytes, Biochim. Biophys. Acta, 1769, 437, 10.1016/j.bbaexp.2007.05.002 Pawitan, 2005, Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts, Breast Cancer Res., 7, R953, 10.1186/bcr1325 Pencheva, 2012, Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis, Cell, 151, 1068, 10.1016/j.cell.2012.10.028 Polyak, 2009, Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits, Nat. Rev. Cancer, 9, 265, 10.1038/nrc2620 Prantl, 2010, Adipose tissue-derived stem cells promote prostate tumor growth, Prostate, 70, 1709, 10.1002/pros.21206 Prockop, 2010, Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs), J. Cell. Mol. Med., 14, 2190, 10.1111/j.1582-4934.2010.01151.x Quail, 2013, Microenvironmental regulation of tumor progression and metastasis, Nat. Med., 19, 1423, 10.1038/nm.3394 Sabatier, 2011, A gene expression signature identifies two prognostic subgroups of basal breast cancer, Breast Cancer Res. Treat., 126, 407, 10.1007/s10549-010-0897-9 Sakurai, 2011, MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers, Cancer Res., 71, 1680, 10.1158/0008-5472.CAN-10-2345 Scapoli, 2010, MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression, Int. J. Immunopathol. Pharmacol., 23, 1229, 10.1177/039463201002300427 Schwarzenbach, 2012, Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients, Breast Cancer Res. Treat., 134, 933, 10.1007/s10549-012-1988-6 Shinagawa, 2010, Mesenchymal stem cells enhance growth and metastasis of colon cancer, Int. J. Cancer, 127, 2323, 10.1002/ijc.25440 Shu, 2001, Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors, J. Biol. Chem., 276, 27488, 10.1074/jbc.M100636200 Shu, 2007, Foxp2 and Foxp1 cooperatively regulate lung and esophagus development, Development, 134, 1991, 10.1242/dev.02846 Spiteri, 2007, Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain, Am. J. Hum. Genet., 81, 1144, 10.1086/522237 Suzuki, 2011, Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization, Mol. Med., 17, 579, 10.2119/molmed.2010.00157 Tavazoie, 2008, Endogenous human microRNAs that suppress breast cancer metastasis, Nature, 451, 147, 10.1038/nature06487 Toullec, 2010, Oxidative stress promotes myofibroblast differentiation and tumour spreading, EMBO Mol Med, 2, 211, 10.1002/emmm.201000073 Tsui, 2013, FoxP2 regulates neurogenesis during embryonic cortical development, J. Neurosci., 33, 244, 10.1523/JNEUROSCI.1665-12.2013 van de Vijver, 2002, A gene-expression signature as a predictor of survival in breast cancer, N. Engl. J. Med., 347, 1999, 10.1056/NEJMoa021967 Vernes, 2011, Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain, PLoS Genet., 7, e1002145, 10.1371/journal.pgen.1002145 Volinia, 2012, Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA, Proc. Natl. Acad. Sci. USA, 109, 3024, 10.1073/pnas.1200010109 Wan, 2013, Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers, Med. Oncol., 30, 378, 10.1007/s12032-012-0378-6 Yan, 2012, Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway, Breast Cancer Res. Treat., 132, 153, 10.1007/s10549-011-1577-0 Yang, 2008, MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN, Cancer Res., 68, 425, 10.1158/0008-5472.CAN-07-2488 Zhang, 2008, A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration, Nat. Genet., 40, 862, 10.1038/ng.157 Zhang, 2010, Dysregulation of miR-15a and miR-214 in human pancreatic cancer, J Hematol Oncol, 3, 46, 10.1186/1756-8722-3-46 Zhou, 2013, LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells, Int. J. Biochem. Cell Biol., 45, 973, 10.1016/j.biocel.2013.02.006